Preclinical Evaluation of the First Adenosine A1 Receptor Partial Agonist Radioligand for Positron Emission Tomography Imaging-Reference-Cited by-同舟云学术

Preclinical Evaluation of the First Adenosine A1 Receptor Partial Agonist Radioligand for Positron Emission Tomography Imaging

Published:2018-10-25 Issue:22 Volume:61 Page:9966-9975
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Guo Min¹^ORCID,Gao Zhan-Guo²,Tyler Ryan¹,Stodden Tyler¹,Li Yang¹,Ramsey Joseph¹,Zhao Wen-Jing¹,Wang Gene-Jack¹,Wiers Corinde E.¹,Fowler Joanna S.¹,Rice Kenner C.³,Jacobson Kenneth A.²^ORCID,Kim Sung Won¹^ORCID,Volkow Nora D.¹⁴

Affiliation:

1. Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland 20892-1013, United States

2. Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-0810, United States

3. Drug Design and Synthesis Section, National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, Maryland 20892, United States

4. National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland 20892-1013, United States

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute on Alcohol Abuse and Alcoholism

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b01009

Reference49 articles.

1. The Role of Extracellular Adenosine in Chemical Neurotransmission in the Hippocampus and Basal Ganglia: Pharmacological and Clinical Aspects